Constitutive overexpression of BCL-2 was detected in both subtypes of DLBCL through distinct mechanisms: chromosomal translocations in GCB DLBCL and NF-κB signaling activation in ABC DLBCL. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.